Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Optical Clearing Method Preserves Critical Brain Tissue Structures

By LabMedica International staff writers
Posted on 30 Sep 2015
A recent paper described the use of a sorbitol-based optical clearing method that provides stable tissue preservation for immunochemical labeling and three-dimensional signal rendering.

Existing tissue clearing reagents contain chemical components that can compromise tissue structure, preventing reproducible anatomical and fluorescence signal stability.

To avoid tissue damage from the clearing reagent, investigators at the RIKEN Brain Science Institute (Saitama, Japan) spent the last five years improving their urea-based Scale clearing reagent. More...
The result, the sorbitol-based ScaleS reagent, was used to prepare tissues from the brains of mice with a genetic model of Alzheimer's disease.

Results published in the September 14, 2015, online edition of the journal Nature Neuroscience revealed that comparative benchmarking of contemporary clearing agents showed that ScaleS provided superior signal and structural preservation. ScaleS permitted optical reconstructions of aged and diseased brain in Alzheimer's disease models, including mapping of three-dimensional networks of amyloid plaques, neurons, and microglia, and multiscale tracking of single plaques by successive fluorescence and electron microscopy.

"The key ingredient of our new formula is sorbitol, a common sugar alcohol," said senior author Dr. Atsushi Miyawaki, senior team leader in cell function dynamics at the RIKEN Brain Science Institute. "By combining sorbitol in the right proportion with urea, we could create transparent brains with minimal tissue damage, that can handle both fluorescent and immunohistochemical labeling techniques, and is even effective in older animals."

"Clearing tissue with ScaleS followed by three-dimensional microscopy has clear advantages over two-dimensional stereology or immunohistochemistry," said Dr. Miyawaki. "Our technique will be useful not only for visualizing plaques in Alzheimer's disease, but also for examining normal neural circuits and pinpointing structural changes that characterize other brain diseases."

Related Links:

RIKEN Brain Science Institute



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
New
Automatic CLIA Analyzer
Shine i6000
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.